Country Office County Coordinators (SSA) at World Health Organisation(WHO), Monrovia, Liberia
Deliverables Minutes of monthly county health coordination meetings Health partners mapping EPI micro-plan available at the Health Facilities, District and County levels Annual RED/ REC operational plans available at Health Facilities, District and County levels Online weekly VPDs ISS and eSurv checklists completion Monthly EPI and VPD data verification and harmonization at the county, district […]
Consultant, Measles Vaccination Campaign at World Health Organisation(WHO), Monrovia, Liberia
Evaluate the measles vaccination coverage arising from the planned campaign that will take place first week of July 2024 in all 15 regions of Liberia. SPECIFIC OBJECTIVES : ü Determine immunization coverage with Measles vaccine by county. ü Determine the number of zero-dose children vaccinated during the campaign ü Determine the number of zero-dose children non-vaccinated during the […]
Consultant, 2025 Update of the Model List of Essential Medicines at World Health Organisation(WHO), Monrovia, Liberia
The WHO Model List of Essential Medicines serves as a guide for countries or regional authorities to prioritize medicines in accordance with local priorities and treatment guidelines. It is updated every 2 years by the WHO Expert Committee on Selection and the Use of Medicines. The latest edition was published in 2023 and contains more […]
Consultant, Training and research for rehabilitation at World Health Organisation(WHO), Monrovia, Liberia
An estimated 2.4 billion people worldwide would benefit from rehabilitation at some point in their lives. This number is expected to increase in the coming years due to people living longer and with more chronic disease and disability. The impact of the COVID-19 pandemic on future rehabilitation needs is also yet to be seen. Despite […]
Roster of consultants, Technical guidance on antimalarial drug efficacy and resistance at World Health Organisation(WHO), Monrovia, Liberia
Prompt treatment with effective antimalarial drugs is a critical component of malaria intervention to reduce malaria cases and deaths. However, resistance to antimalarial drugs challenges our ability to save lives threatened by malaria and to eliminate the burden that malaria places on individuals and societies. Measurement of drug efficacy and resistance in malaria is complex. […]
Consultant, Immunization Agenda 2030 (IA2030) Monitoring and Evaluation (M&E), Data Strengthening and Use Working Groups (DSUWG) at World Health Organisation(WHO), Monrovia, Liberia
WHO’s Immunization, Vaccines and Biologicals (IVB) Department coordinates the Immunization Agenda 2030 (IA2030) Monitoring and Evaluation (M&E) and the Data Strengthening and Use Working Groups (DSUWG). The IA2030, endorsed by the World Health Assembly in August 2020, envisions a world where everyone, everywhere, at every age, fully benefits from vaccines to improve health and well-being. […]
